8 research outputs found
Manual administrativo y financiero para la unidad educativa particular “Thomas Russell Crampton” ubicada en la ciudad de Cayambe provincia de Pichincha
Diseñar un manual administrativo y financiero para la Unidad Educativa Particular “Thomas Russell Crampton” en la ciudad de Cayambe, provincia de Pichincha.La Unidad Educativa Particular “Thomas Russell Crampton”, se encuentra localizada en la Avenida Atahualpa OE 10-60 y Santiago, en la ciudad de Cayambe provincia de Pichincha, la institución educativa ofrece servicios educativos de calidad, su propuesta educativa es: • Educación Inicial: Inicial I e Inicial II. • Educación General Básica: desde Preparatoria hasta 7mo grado. • Bachilletato General Unificado: desde 1ero BGU a 3ero BGU. • Servicios Complementarios: Inglés de alto nivel, tecnologías de la información, formación emprendedora, educación artística y natación. Los servicios complementarios, el compromiso de educar formando emprendedores y su personal altamente capacitado han permitido su posicionamiento Institucional desde hace 13 años. En el diagnóstico situacional se pudo evidenciar que la Unidad Educativa realiza todos sus procesos de manera empírica, lo que ha originado en repetidas ocasiones inconvenientes en el desempeño de las actividades de la institución; así como, en la toma de decisiones; por lo cual, el diseño de un MANUAL ADMINISTRATIVO FINANCIERO es importante como herramienta de apoyo y mejoramiento en el cumplimiento de los procesos que se realizan para el cumplimiento de sus objetivos institucionales. Esto también permitirá cubrir las necesidades de sus clientes tanto internos como externos y lograr el crecimiento institucional deseado. Este trabajo de investigación contiene cinco capítulos; en donde, el primer capítulo abarca la fundamentación teórica que sustentará el desarrollo del manual sustentado a través de documento bibliográficos y científicos que contribuirán a la comprensión de los lectores. En el segundo capítulo corresponde a los procedimientos metodológicos a aplicar utilizando herramientas y técnicas de investigación adecuadas para el estudio. El tercer capítulo contiene el diagnóstico situacional de la Institución mediante la utilización de la matriz FODA para el análisis. El cuarto capítulo consiste en diseño de la propuesta administrativa y financiera. y, por último, el capítulo cinco donde se evidencia la validación técnica de la propuesta diseñada para la Unidad Educativa.Ingenierí
Anti-Spike antibodies 3 months after SARS-CoV-2 mRNA vaccine booster dose in patients on hemodialysis: the prospective SENCOVAC study
Background: Patients on hemodialysis are at high-risk for complications derived from coronavirus disease 2019 (COVID-19). The present analysis evaluated the impact of a booster vaccine dose and breakthrough severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on humoral immunity 3 months after the booster dose. Methods: This is a multicentric and prospective study assessing immunoglobulin G anti-Spike antibodies 6 and 9 months after initial SARS-CoV-2 vaccination in patients on hemodialysis that had also received a booster dose before the 6-month assessment (early booster) or between the 6- and 9-month assessments (late booster). The impact of breakthrough infections, type of vaccine, time from the booster and clinical variables were assessed. Results: A total of 711 patients [67% male, median age (range) 67 (20-89) years] were included. Of these, 545 (77%) received an early booster and the rest a late booster. At 6 months, 64 (9%) patients had negative anti-Spike antibody titers (3% of early booster and 29% of late booster patients, P =. 001). At 9 months, 91% of patients with 6-month negative response had seroconverted and there were no differences in residual prevalence of negative humoral response between early and late booster patients (0.9% vs 0.6%, P =. 693). During follow-up, 35 patients (5%) developed breakthrough SARS-CoV-2 infection. Antibody titers at 9 months were independently associated with mRNA-1273 booster (P =. 001), lower time from booster (P =. 043) and past breakthrough SARS-CoV-2 infection (P <. 001). Conclusions: In hemodialysis patients, higher titers of anti-Spike antibodies at 9 months were associated with mRNA-1273 booster, lower time from booster and past breakthrough SARS-CoV-2 infectionThe present project has been supported by Fresenius Medical Care, Diaverum, Vifor Pharma, Vircell, Fundación Renal Iñigo Álvarez de Toledo and ISCIII FEDER funds RICORS2040 (RD21/0005
Guía Mexicana para el Diagnóstico y el Tratamiento de la Urticaria
La urticaria es una enfermedad que padece una quinta parte de la población en algún momento de su vida. Las guías inter- nacionales recientes han propuesto unos cambios de fondo en su diagnóstico y tratamiento, por lo que había la necesidad de crear una guía nacional y multidisciplinaria, con base amplia en los gremios de especialistas y médicos de primer contacto en México.
ABSTRACT
Urticaria is a disease that a fifth of the population shall suffer once in a lifetime. Recent clinical guidelines have proposed some fundamental changes in the diagnosis and treatment of urticaria, making the development of a national, multidisciplinary guideline, with wide acceptability among different professional groups –both specialists and primary health care workers–, necessary in Mexico
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
Objectives: The objective of this study was to estimate the association between tocilizumab or corticosteroids and the risk of intubation or death in patients with coronavirus disease 19 (COVID-19) with a hyperinflammatory state according to clinical and laboratory parameters.
Methods: A cohort study was performed in 60 Spanish hospitals including 778 patients with COVID-19 and clinical and laboratory data indicative of a hyperinflammatory state. Treatment was mainly with tocilizumab, an intermediate-high dose of corticosteroids (IHDC), a pulse dose of corticosteroids (PDC), combination therapy, or no treatment. Primary outcome was intubation or death; follow-up was 21 days. Propensity score-adjusted estimations using Cox regression (logistic regression if needed) were calculated. Propensity scores were used as confounders, matching variables and for the inverse probability of treatment weights (IPTWs).
Results: In all, 88, 117, 78 and 151 patients treated with tocilizumab, IHDC, PDC, and combination therapy, respectively, were compared with 344 untreated patients. The primary endpoint occurred in 10 (11.4%), 27 (23.1%), 12 (15.4%), 40 (25.6%) and 69 (21.1%), respectively. The IPTW-based hazard ratios (odds ratio for combination therapy) for the primary endpoint were 0.32 (95%CI 0.22-0.47; p < 0.001) for tocilizumab, 0.82 (0.71-1.30; p 0.82) for IHDC, 0.61 (0.43-0.86; p 0.006) for PDC, and 1.17 (0.86-1.58; p 0.30) for combination therapy. Other applications of the propensity score provided similar results, but were not significant for PDC. Tocilizumab was also associated with lower hazard of death alone in IPTW analysis (0.07; 0.02-0.17; p < 0.001).
Conclusions: Tocilizumab might be useful in COVID-19 patients with a hyperinflammatory state and should be prioritized for randomized trials in this situatio
EDUCACIÓN AMBIENTAL Y SOCIEDAD. SABERES LOCALES PARA EL DESARROLLO Y LA SUSTENTABILIDAD
Este texto contribuye al análisis científico de varias áreas del conocimiento como la filosofía social, la patología, la educación para el cuidado del medio ambiente y la sustentabilidad que inciden en diversas unidades de aprendizaje de la Licenciatura en Educación para la Salud y de la Maestría en Sociología de la SaludLas comunidades indígenas de la sierra norte de Oaxaca México, habitan un territorio extenso de biodiversidad. Sin que sea una área protegida y sustentable, la propia naturaleza de la región ofrece a sus visitantes la riqueza de la vegetación caracterizada por sus especies endémicas que componen un paisaje de suma belleza
Fibromyalgia as a Heterogeneous Condition: Subgroups of Patients Based on Physical Symptoms and Cognitive-Affective Variables Related to Pain
Fibromyalgia (FM) is a chronic syndrome characterized by heterogeneous clinical manifestations, and knowing
this variability can help to develop tailored treatments. To understand better the heterogeneity of FM the present crosssectional
study analyzed the role of several physical symptoms (pain, fatigue and poor sleep quality) and cognitive-affective
variables related to pain (pain catastrophizing, pain vigilance, self-efficacy in pain management, and pain acceptance) in the
configuration of clinical profiles. A sample of 161 women with FMfulfilled an interview and several self-report measures to
explore physical symptoms, cognitive-affective variables, disability and psychopathology. To establish FM groups a
hierarchical cluster analysis was performed. The findings revealed three clusters that differed in the grouping variables,
Wilks’ λ = .17, F(14, 304) = 31.50, p < .001, ηp2 = .59.Group 1 (n = 72) was characterized by high physical and psychological
affectation, Group 2 (n = 19) by lowphysical affectation and high pain self-efficacy, and Group 3 (n = 70) bymoderate physical
affectation and low pain catastrophizing. The external validation of the clusters was confirmed, Wilks’ λ = .72, F(4, 314) =
14.09, p < .001, ηp2 = .15, showing Group 1 the highest levels of FMimpact and psychopathological distress. Considering the
distinctive clinical characteristics of each subgroup therapeutic strategies addressed to the specific needs of each group were
suggested. Assessing FM profiles may be key for a better understanding and approach of this syndrome.Spanish Government PSI2014-58379-P
PID2019-109612GB-I00/AEI/10.13039/50110001103
Mexican Guidelines on the Diagnosis and Treatment of Urticaria
Background: Urticaria is a disease that a fth of the population shall suffer once in a lifetime. Recent clinical guidelines have proposed some fundamental changes in the diagnosis and treatment of urticaria, making the development of a national, multidisciplinary guideline, with wide acceptability among different professional groups –both specialists and primary health care workers–, necessary in Mexico.
Material and method: Internationally recognized tools for guideline- development were used. An interdisciplinary group of clinical experts (some of them knowledgeable in methodology of guideline develop- ment) determined the objectives and scope of the Evidence Based Clinical Practice Guideline with SCOPE. It was decided to adapt and transculturize international guidelines on the diagnosis and treatment of urticaria. With AGREE-II three high-quality guidelines (Zuberbier 2014, Sánchez-Borges 2012, Powell 2007) were selected to function as basic guidelines (BG). A set of Clinical Questions was formulated that lead to recommendations/suggestions, based on these BG, taking into account the cultural and economic background of Mexico, according to GRADE recommendation development.
Results: By a formal process of discussion and voting during several working-sessions, experts and rst level healthcare physicians deter- mined the wording of the nal guideline, taking particularly care of developing a document, adjusted to the reality, values and preferences of the Mexican patients. The use of oral second generation, non-sedating antihistamines as rst line treatment is emphasized.
Conclusion: This document is an Evidence Based Clinical Practice Guideline for the diagnosis and treatment of acute and chronic urticaria, based on three, high quality, international guidelines. It was developed by a multidisciplinary group. Tables and algorithms make the guideline user-friendly for both, rst line health care physicians and specialist